Edward V. Nunes

Edward V. Nunes

Auto-generated profile, based on publicly available information

Edward V. Nunes

Department of Psychiatry Columbia University Irving Medical Center New York NY USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in The Lancet
Verified
Journal Article
Closed access
JLJoshua D Lee
Joshua D Lee
ENEdward V Nunes
Edward V Nunes
PNPatricia Novo
Patricia Novo
KBKen Bachrach
Ken Bachrach
GBGenie L Bailey
Genie L Bailey
JRJohn Rotrosen
John Rotrosen

21 April 2004 in JAMA
Verified
Journal Article
Closed access
PDF file
ENEdward V. Nunes
Edward V. Nunes
FLFrances R. Levin
Frances R. Levin
Review from JAMA — Treatment of Depression in Patients With Alcohol or Other Drug Dependence — A Meta-analysis — ContextDepression and substance abuse are common and costly disorders that frequently co-occur, but controversy about effective treatment for patients with both disorders persists.ObjectiveTo conduct a systematic review and meta-analysis to quantify the efficacy of antidepressant medications for treatment of combined depression and substance use disorders.Data SourcesPubMed, MEDLINE, and Cochrane database search (1970-2003), using the keywords antidepressant treatment or treatment depressed in conjunction with each of the following alcohol dependence, benzodiazepine dependence, opiate dependence, cocaine dependence, marijuana dependence, and methadone; a search of bibliographies; and consultation with experts in the field.Study SelectionAmong inclusion criteria used for study selection were prospective, parallel group, double-blind, controlled clinical trials with random assignment to an antidepressant medication or placebo for which trial patients met standard diagnostic criteria for current alcohol or other drug use and a current unipolar depressive disorder. Of the more than 300 citations extracted, 44 were placebo-controlled clinical trials, 14 of which were selected for this analysis and included 848 patients: 5 studies of tricyclic antidepressants, 7 of selective serotonin re-uptake inhibitors, and 2 from other classesData ExtractionWe independently screened the titles and abstracts of each citation, identified placebo-controlled trials of patients with both substance dependence and depression, applied the inclusion criteria, and reached consensus. Data on study methods, sample characteristics, and depression and substance use outcomes were extracted. The principal measure of effect size was the standardized difference between means on the Hamilton Depression Scale (HDS).Data SynthesisFor the HDS score, the pooled effect size from the random-effects model was 0.38 (95% confidence interval, 0.18-0.58). Heterogeneity of effect on HDS across studies was significant (P <.02), and studies with low placebo response showed larger effects. Moderator analysis suggested that diagnostic methods and concurrent psychosocial interventions influenced outcome. Studies with larger depression effect sizes (>0.5) demonstrated favorable effects of medication on measures of quantity of substance use, but rates of sustained abstinence were low.ConclusionsAntidepressant medication exerts a modest beneficial effect for patients with combined depressive- and substance-use disorders. It is not a stand-alone treatment, and concurrent therapy directly targeting the addiction is also indicated. More research is needed to understand variations in the strength of the effect, but the data suggest that care be exercised in the diagnosis of depression–either by observing depression to persist during at least a brief period of abstinence or through efforts by clinical history to screen out substance-related depressive symptoms.

1 February 2006 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
EAEfrat Aharonovich
Efrat Aharonovich
DHDeborah S. Hasin
Deborah S. Hasin
ABAdam C. Brooks
Adam C. Brooks
XLXinhua Liu
Xinhua Liu
ABAdam Bisaga
Adam Bisaga
ENEdward V. Nunes
Edward V. Nunes

22 August 2011 in The American Journal of Drug and Alcohol Abuse
Verified
Journal Article
Closed access
PDF file
MHMei-Chen Hu
Mei-Chen Hu
MPMartina Pavlicova
Martina Pavlicova
ENEdward V. Nunes
Edward V. Nunes
Background: In clinical trials of behavioral health interventions, outcome variables often take the form of counts, such as days using substances or episodes of unprotected sex. Classically, count data follow a Poisson distribution; however, in practice such data often display greater heterogeneity in the form of excess zeros (zero-inflation) or greater spread in the values (overdispersion) or both. Greater sample heterogeneity may be especially common in community-based effectiveness trials, where broad eligibility criteria are implemented to achieve a generalizable sample. Objectives: This article reviews the characteristics of Poisson model and the related models that have been developed to handle overdispersion (negative binomial (NB) model) or zero-inflation (zero-inflated Poisson (ZIP) and Poisson hurdle (PH) models) or both (zero-inflated negative binomial (ZINB) and negative binomial hurdle (NBH) models). Methods: All six models were used to model the effect of an HIV-risk reduction intervention on the count of unprotected sexual occasions (USOs), using data from a previously completed clinical trial among female patients (N = 515) participating in community-based substance abuse treatment (Tross et al. Effectiveness of HIV/AIDS sexual risk reduction groups for women in substance abuse treatment programs: Results of NIDA Clinical Trials Network Trial. J Acquir Immune Defic Syndr 2008; 48(5):581–589). Goodness of fit and the estimates of treatment effect derived from each model were compared. Results: The ZINB model provided the best fit, yielding a medium-sized effect of intervention. Conclusions and Scientific Significance: This article illustrates the consequences of applying models with different distribution assumptions on the data. If a model used does not closely fit the shape of the data distribution, the estimate of the effect of the intervention may be biased, either over- or underestimating the intervention effect.

1 January 2010 in American Journal of Psychiatry
Verified
Journal Article
Closed access
DHDenise Hien
Denise Hien
HJHuiping Jiang
Huiping Jiang
ACAimee N.C. Campbell
Aimee N.C. Campbell
MHMei-Chen Hu
Mei-Chen Hu
GMGloria M. Miele
Gloria M. Miele
ENEdward V. Nunes
Edward V. Nunes

1 June 2014 in American Journal of Psychiatry
Verified
Journal Article
Closed access
ACAimee N.C. Campbell
Aimee N.C. Campbell
ENEdward V. Nunes
Edward V. Nunes
AMAbigail G. Matthews
Abigail G. Matthews
MSMaxine Stitzer
Maxine Stitzer
GMGloria M. Miele
Gloria M. Miele
UGUdi E. Ghitza
Udi E. Ghitza